In Silico Prediction of Torsadogenic Drug-Induced Proarrhythmias from Action Potential Waveforms in O'Hara-Rudy Human Cardiac Ventricular Model

Author(s):  
Tetsuji Itoh ◽  
Chiaki Nakamori ◽  
Shota Saiki ◽  
Yuichi Utsumi ◽  
Shigeyuki Fujimoto ◽  
...  
2021 ◽  
Author(s):  
Yangyang Lin ◽  
Sam Z. Grinter ◽  
Zhongju Lu ◽  
Xianjin Xu ◽  
Hong Zhan Wang ◽  
...  

AbstractCardiac arrhythmias are the most common cause of sudden cardiac death worldwide. Lengthening the ventricular action potential duration (APD) either congenitally or via pathologic or pharmacologic means, predisposes to a life-threatening ventricular arrhythmia, Torsade de Pointes. IKs, a slowly activating K+ current plays a role in action potential repolarization. In this study, we screened a chemical library in silico by docking compounds to the voltage sensing domain (VSD) of the IKs channel. Here we show that C28 specifically shifted IKs VSD activation in ventricle to more negative voltages and reversed drug-induced lengthening of APD. At the same dosage, C28 did not cause significant changes of the normal APD in either ventricle or atrium. This study provides evidence in support of a computational prediction of IKs VSD activation as a potential therapeutic approach for all forms of APD prolongation. This outcome could expand the therapeutic efficacy of a myriad of currently approved drugs that may trigger arrhythmias.Significance statementC28, identified by in silico screening, specifically facilitated voltage dependent activation of a cardiac potassium ion channel, IKs. C28 reversed drug-induced prolongation of action potentials, but minimally affected the normal action potential at the same dosage. This outcome supports a computational prediction of modulating IKs activation as a potential therapy for all forms of action potential prolongation, and could expand therapeutic efficacy of many currently approved drugs that may trigger arrhythmias.


2022 ◽  
Vol 12 ◽  
Author(s):  
Yinping Shi ◽  
Yuqing Hua ◽  
Baobao Wang ◽  
Ruiqiu Zhang ◽  
Xiao Li

Drug induced nephrotoxicity is a major clinical challenge, and it is always associated with higher costs for the pharmaceutical industry and due to detection during the late stages of drug development. It is desirable for improving the health outcomes for patients to distinguish nephrotoxic structures at an early stage of drug development. In this study, we focused on in silico prediction and insights into the structural basis of drug induced nephrotoxicity, based on reliable data on human nephrotoxicity. We collected 565 diverse chemical structures, including 287 nephrotoxic drugs on humans in the real world, and 278 non-nephrotoxic approved drugs. Several different machine learning and deep learning algorithms were employed for in silico model building. Then, a consensus model was developed based on three best individual models (RFR_QNPR, XGBOOST_QNPR, and CNF). The consensus model performed much better than individual models on internal validation and it achieved prediction accuracy of 86.24% external validation. The results of analysis of molecular properties differences between nephrotoxic and non-nephrotoxic structures indicated that several key molecular properties differ significantly, including molecular weight (MW), molecular polar surface area (MPSA), AlogP, number of hydrogen bond acceptors (nHBA), molecular solubility (LogS), the number of rotatable bonds (nRotB), and the number of aromatic rings (nAR). These molecular properties may be able to play an important part in the identification of nephrotoxic chemicals. Finally, 87 structural alerts for chemical nephrotoxicity were mined with f-score and positive rate analysis of substructures from Klekota-Roth fingerprint (KRFP). These structural alerts can well identify nephrotoxic drug structures in the data set. The in silico models and the structural alerts could be freely accessed via https://ochem.eu/article/140251 and http://www.sapredictor.cn, respectively. We hope the results should provide useful tools for early nephrotoxicity estimation in drug development.


2013 ◽  
Vol 29 (16) ◽  
pp. 2062-2063 ◽  
Author(s):  
Alexey Lagunin ◽  
Sergey Ivanov ◽  
Anastasia Rudik ◽  
Dmitry Filimonov ◽  
Vladimir Poroikov

2019 ◽  
Vol 39 (8) ◽  
pp. 1224-1232 ◽  
Author(s):  
Xueyan Cui ◽  
Juan Liu ◽  
Jinfeng Zhang ◽  
Qiuyun Wu ◽  
Xiao Li

2015 ◽  
Vol 19 (4) ◽  
pp. 945-953 ◽  
Author(s):  
Hui Zhang ◽  
Peng Yu ◽  
Teng-Guo Zhang ◽  
Yan-Li Kang ◽  
Xiao Zhao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document